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Release of rosmarinic acid from semisolid formulations and its 
penetration through human skin ex vivo
The aim of this study was to evaluate the release of ros-
marinic acid (RA) from the experimental topical formula-
tions with the Melissa offi  cinalis L. extract and to evaluate its 
penetration through undamaged human skin ex vivo. The 
results of the in vitro release study showed that higher 
amounts of RA were released from the emulsion vehicle 
when lemon balm extract was added in its dry form. An 
inverse correlation was detected between the released 
amount of RA and the consistency index of the formula-
tion. Diff erent penetration of RA into the skin may be infl u-
enced by the characteristics of the vehicle as well as by the 
form of the extract. The results of penetration assessment 
showed that the intensity of RA penetration was infl uenced 
by its lipophilic properties: RA was accumulating in the 
epidermis, while the dermis served as a barrier, impeding 
its deeper penetration.
Keywords: human skin penetration, rosmarinic acid, rheol-
ogy, release
Atopic dermatitis is one of the most common skin diseases. Since dermatologic prod-
ucts from natural raw materials are becoming increasingly popular, it is relevant to pro-
duce a semisolid transdermal preparation that would have not only natural active ingre-
dients, but a natural base as well. A clinical study performed by Lee et al. (1) showed »the 
possible clinical use of rosmarinic acid (RA) as a therapeutic agent for atopic dermatitis«. 
Rosmarinic acid demonstrated cellular protective properties against the damaging radical 
species induced by UVB radiation (2). Scientifi c literature describes penetration studies 
with RA using Caco-2 cell monolayers (3), which refl ects penetration of RA through the 
intestinal wall. Research has shown (3) that the botanical matrix had no eff ect on RA pene-
tration through the Caco-2 cell monolayer. Lee et al. (1) performed a clinical study to eval-
uate the eff ect of a topical RA preparation. However, in our review of scientifi c literature, 
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RA is the key active ingredient of a Melissa offi  cinalis L. extract (4). European Pharmaco-
poeia, monograph Melissa offi  cinalis L. leaves, states that Melissa offi  cinalis L. leaves should 
contain at least 4 % of hydroxycinnamic acids expressed as RA. RA is also known as an 
antiviral (5), anti-infl ammatory (5), antioxidant (6), photoprotective (2) and anti-prolifera-
tive (6) component of Melissa offi  cinalis L., which makes it relevant to apply the Melissa of-
fi cinalis L. extract as a natural source of RA in the modeling of semisolid formulations.
The aim of this study was to evaluate the release of rosmarinic acid from the experi-
mental topical formulations with the Melissa offi  cinalis L. extract and to evaluate its pene-
tration through undamaged human skin ex vivo.
EXPERIMENTAL
Materials
Rosmarinic acid, HPLC-grade acetonitrile, and acetic acid were purchased from Sig-
ma Aldrich Chemie GmBH (Germany). Standardized dry lemon balm extract (sicc. Extrac-
tum Melissae offi  cinalis) was purchased from Naturex (France).
Methods
Preparation of semisolid formulations. – The components of the formulation are listed in 
Table I. The choice of the components for the ointment and w/o cream semisolid vehicles 
were developed with reference to the earlier published research data (7). In accordance 
with the study of Lee et al. (1), the formulations were produced with 4 % of dry lemon balm 
extract containing 80 mg g–1 RA. Formulations were prepared according to the general 
technological principles of semisolid preparation.
Quantifi cation of rosmarinic acid by HPLC. – The amount of RA was evaluated by apply-
ing the capillary HPLC method, which was developed and validated, using the Agilent 
1260 Infi nity Capillary LC System (Agilent Technologies, USA) with an Agilent diode array 
detector. The separation was performed on a C18 ACE (5 µm) 150x0.5 mm i.d. column. The 




























































N 1   6.0 5.0 5.0 – 10.0 3.0 67.0 – – 4.0
N 2 15.0 – – 10.0 10.0 3.0 58.0 – – 4.0
N 3   5.0 – – 10.0 10.0 3.0 33.0 35.0 – 4.0
N 4   5.0 – – 10.0 10.0 3.0 37.0 – 35.0 –
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mobile phase consisted of solvents A (0.5 % aqueous solution of acetic acid, V/V) and B 
(acetonitrile) using the following gradient elution: 23 % of B at time 0, 40 % of B at 10 min, 
and 70 % of B at 11–15 min, and then returned to the initial conditions by 10-minute re-
equilibration, with the total run time of 25 minutes. The analysis was carried out at a fl ow 
rate of 10 µL min–1, with the detection wavelength set at 330 nm.
Rheological fl ow behavior test. – The test (n = 5) was performed using the Carri-med CSL2 
500 rheometer (TA Instruments, Germany), applying the cone-and-plate geometry system 
(cone diameter 60 mm, angle 2o, sample thickness 150 µm). The shear rate was increased 
from 0 to 500 s–1 for 2 minutes. The rheological properties of the samples were determined 
according to the Oswald de Waele (8) equation:
  σ = K γ·n
where σ is shear stress (Pa), γ·  is shear rate (s–1), and K is the consistency index [(Pa s)n] 
which is the indicator of viscosity. The fl ow behavior index (n) is a dimensionless number 
that indicates the closeness to the Newtonian fl ow. For a Newtonian liquid n = 1 for a dila-
tant fl uid n > 1, and for a pseudoplastic fl uid n < 1 (8).
In vitro release study. – In vitro release experiments were performed using modifi ed 
Franz-type diff usion cells (9). The semisolid sample (1.00 ± 0.02 g) was placed into the cell 
with a dialysis membrane Cuprophan® (Medicell International Ltd., UK). The area of the 
diff usion was 1.77 cm2. Thermostated (37 ± 0.2 oC) purifi ed water acted as the acceptor 
medium. The medium was stirred using a magnetic stirrer. Samples from the acceptor 
solution were taken at 1, 2, 4, and 6 h and were immediately replaced with the same vol-
ume of fresh acceptor solution.
Ex vivo penetration through the full-thickness undamaged human skin. – Abdominal skin 
of Caucasian women (age range 25–40 years) was obtained from the Department of Plastic 
and Reconstructive Surgery (the Hospital of the Lithuanian University of Health Sciences, 
Lithuania) a er cosmetic surgery. It was stored at –20 °C for not longer than 6 months be-
fore use. Kaunas Regional Biomedical Research Ethics Commi ee had approved the use 
of human skin for transdermal penetration studies. A Bronaugh-type fl ow-through diff u-
sion cell with full-thickness human skin was used for ex vivo skin penetration experiments 
(n = 3). The experiment was performed according to the methods proposed by Kezutyte et 
al. and Zilius et al. (9, 10).
Statistical data evaluation was performed using the SPSS so ware with one-way 
ANOVA. Tukey’s post hoc test was performed for multiple comparisons.
RESULTS AND DISCUSSION
Stable vehicles were developed in our previous research (7). Vehicles contained all 
components indicated in Table I, except Melissa offi  cinalis L. extract. Formulation N1 was a 
hydrophobic vehicle with solid paraffi  n and vaseline, formulation N2 a hydrophobic ve-
hicle with beeswax instead of paraffi  n and honey instead of vaseline, formulation N3 was 
an emulsion vehicle with dry Melissa offi  cinalis L. extract, and formulation N4 was an emul-
sion vehicle with aqueous Melissa offi  cinalis L. extract. During the fi rst stage of the study, 
we evaluated the infl uence of the semisolid bases and the addition of the extract on the 
rheological characteristics of the formulations by determining their consistency index and 
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fl ow behavior index. Modifi cation of viscosity is an important part of the preparation of 
semisolid formulations and is regarded to be a critical quality a ribute in the development 
stage of the product (11). To evaluate the possible eff ect of temperature on the structure of 
semisolid formulations during their storage period, we selected the temperature of 30 oC, 
which was approximate to the melting temperature of the experimental formulations as 
well as to the skin surface temperature. The obtained results showed that all the investi-
gated formulations displayed pseudoplastic characteristics. The results of the experiments 
showed that addition of the Melissa offi  cinalis L. extract signifi cantly reduced consistency 
indices of the formulations and increased their fl ow behavior indices compared to the 
rheological characteristics of the vehicles (Fig. 1).
The addition of dry Melissa offi  cinalis L. extract had the greatest infl uence on the rheo-
logical properties of N3 as compared to those of hydrophobic formulations (N1 and N2). 
The results showed that the addition of the active substance in its dry form had a greater 
impact on the rheological properties of emulsion formulations. The calculated consistency 
and fl ow behavior indices refl ected the eff ect of the Melissa offi  cinalis L. extract on the weak-
ening of the structure of semisolid formulations, which may aff ect the expiry date of for-
mulations.
The results of the RA release studies were in line with the published data, demonstrat-
ing that the release of drug substances from semisolid vehicles is infl uenced not only by 
the properties of the drug molecule, but also by the properties of the vehicle (12). Data 
presented in Fig. 2 show that higher amounts of RA were released from the vehicles (N1, 
N2, and N3) when the Melissa offi  cinalis L. extract was added in its dry form compared to 
formulation N4, which contained an aqueous lemon-balm extract. The results of the ex-
periments demonstrated that formulation N4 released the lowest amounts (less than 1 %) 
of RA (Fig. 2) within 6 hours of testing. Hypothetically, it can be stated that the diff usion 
of RA from the aqueous phase of this emulsion was hampered by the inner lipophilic 
phase. The highest amounts (39.6 %) of RA were released from the emulsion vehicle N3 
within 6 hours. Results of the statistical analysis revealed a statistically signifi cant (p < 0.01) 
inverse correlation (Spearman’s correlation coeffi  cient of –0.82) between the consistency 
index and the amount of RA released from the formulations within 6 hours of the experi-
ment. However, no statistically signifi cant diff erences between N1, N2 or N4 were found. 
Fig. 1. Rheological properties of semisolid formulations with Melissa offi  cinalis L. extract and vehicles 
at 30 °C: a) consistency index, b) fl ow behaviour index (mean ± SD, n = 5).
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A statistically signifi cant (p < 0.05) diff erence of RA release from N3 could be determined 
by the consistency index, which was signifi cantly (p < 0.05) diff erent from that of the emul-
sion base. Since the consistency index indicates viscosity (8), and viscosity, in turn, has an 
inversely proportional infl uence on the diff usion process, a decrease in viscosity could 
lead to an increase in the substance release rate.
Penetration of RA from the aqueous Melissa offi  cinalis L. extract through the skin was 
infl uenced only by the diff usion process and the properties of the active substance itself. 
It was therefore, used as a penetration reference. Penetration tests through undamaged 
human skin within 24 hours revealed that the aqueous Melissa offi  cinalis L. extract pene-
trated the epidermis and the dermis; unfortunately, the amounts traced in the dermis 
could not be assessed quantitatively. The results confi rmed the data presented in the lit-
erature, indicating that passive diff usion of a solute from its vehicle into the skin is deter-
mined by the unique molecular and physical properties of the diff usant, the vehicle and 
the skin (13).
The results of the study showed that RA from hydrophobic formulations N1 and N2 
penetrated the epidermis within 24 hours of the experiment (Table II), and the amount 
penetrated (0.20 % and 0.15 %, respectively) was half that of RA from the reference. No RA 
was found in the dermis. The obtained results also showed that the penetration of RA was 
limited by the release of the active substance from the dosage form. It should be noted that 
hydrophobic formulations contain 15 % of substances that form a fi lm on the surface of the 
skin (beeswax, paraffi  n, or petroleum jelly) (14), which may constitute an additional bar-
rier to RA. RA that penetrated from N4 was also traced only in the epidermis (0.22 %). The 
results of the statistical analysis revealed that there was no statistically signifi cant diff er-
ence in the amounts of RA that penetrated the epidermis from formulations N1, N2, and 
N4. The results of the experiments demonstrated that the penetration of RA from formula-
tion N3 into the epidermis was approximately 6-fold higher (1.08 %) compared to the re-
sults a er the application of N1, N2 and N4. The quantities of RA were signifi cantly high-
er in the epidermis when emulsion N3 was used as a vehicle for RA if compared to the 
application of the reference. The results of the penetration assessment showed that RA was 
accumulating in the epidermis, and the hydrophilic dermis acted as a barrier preventing 
deeper penetration and entry of RA into systemic blood fl ow. Data showed that the pene-
tration of RA from N3 was enhanced because the penetration was greater than the refer-
Fig. 2. Release profi les of rosmarinic acid from semisolid formulations with Melissa offi  cinalis L. ex-
tract: a) N1, N2 and N4, b) N3 (mean ± SD, n = 3).
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ence. The enhancer was probably olive oil, which was one of the components of the vehicle. 
Olive oil contains high amounts of oleic acid, which is known as a penetration enhancer 
(15). RA was not found in the acceptor phase of any sample. These results have show that 
RA used topically generates only local eff ects.
CONCLUSIONS
The results of the in vitro release study showed that higher amounts of RA were re-
leased from the emulsion vehicle when the Melissa offi  cinalis L. extract was added in its dry 
form. An inverse correlation was detected between the amount of RA released and the 
consistency index of the vehicle, the decreasing viscosity of the formulations resulting in 
higher amounts of RA being released. Diff erences in penetration of RA into the skin may 
be infl uenced by the characteristics of the vehicle as well as by the form of the extract. The 
results have shown that RA used topically generates only local eff ects. Further studies are 
required for the development of more eff ective lemon balm extract-containing formula-
tions that would ensure a be er penetration of RA into the skin.
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